Interestingly, evidence suggests that combining TNFα inhibitors with thiopurines, such as azathioprine, does not significantly increase the risk of skin cancer beyond what is observed with thiopurine monotherapy [20,21]. This evidence concerns the gene TNF and skin cancer.